Challenges in Multi-Country Registry Harmonization
Challenges in Multi-Country Registry Harmonization Overcoming the Challenges of Multi-Country Registry Harmonization As pharmaceutical companies expand global real-world evidence (RWE) efforts, the need for harmonized multi-country registries has never been greater. These registries enable data pooling across populations, improve generalizability, and support regulatory decisions across regions. However, harmonizing registry data and operations across multiple countries…
Read More “Challenges in Multi-Country Registry Harmonization” »